Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Lipid-lowering therapies for cardiovascular disease prevention and management in primary care: PEER umbrella systematic review of systematic reviews
N Dugré, AJ Lindblad, D Perry, GM Allan… - Canadian Family …, 2023 - cfp.ca
Objective To assess the benefits and harms of lipid-lowering therapies used to prevent or
manage cardiovascular disease including bile acid sequestrants (BAS), ezetimibe, fibrates …
manage cardiovascular disease including bile acid sequestrants (BAS), ezetimibe, fibrates …
Primary prevention of ASCVD and T2DM in patients at metabolic risk: an Endocrine Society clinical practice guideline
JL Rosenzweig, GL Bakris, LF Berglund… - The Journal of …, 2019 - academic.oup.com
Objective To develop clinical practice guidelines for the primary prevention of atherosclerotic
cardiovascular disease (ASCVD) and type 2 diabetes mellitus (T2DM) in individuals at …
cardiovascular disease (ASCVD) and type 2 diabetes mellitus (T2DM) in individuals at …
NADPH oxidase inhibition in fibrotic pathologies
K Bernard, VJ Thannickal - Antioxidants & Redox Signaling, 2020 - liebertpub.com
Significance: Fibrosis is a stereotypic, multicellular tissue response to diverse types of
injuries that fundamentally result from a failure of cell/tissue regeneration. This complex …
injuries that fundamentally result from a failure of cell/tissue regeneration. This complex …
Orlistat‐Induced Gut Microbiota Modification in Obese Mice
J Ke, Y An, B Cao, J Lang, N Wu… - … and Alternative Medicine, 2020 - Wiley Online Library
Introduction. Accumulating evidence has indicated that alterations of gut microbiota have
been involved in various metabolic diseases. Orlistat, a reversible inhibitor of pancreatic and …
been involved in various metabolic diseases. Orlistat, a reversible inhibitor of pancreatic and …
The impact of oxidative stress on the activity of adenosine deaminase and its isoenzymes in nephropathy patients from Wasit-Iraq
Diabetes mellitus is a group of metabolic disorders that share with symptoms of
hyperglycemia led to elevated free radical activity. Hyperglycemia is linked to a higher level …
hyperglycemia led to elevated free radical activity. Hyperglycemia is linked to a higher level …
[HTML][HTML] Reducing the Burden of Diabetes Mellitus: Is it Achievable?
Diabetes mellitus is rapidly on the rise globally, particularly in low-and middle-income
countries. Pakistan has emerged with the highest prevalence of diabetes by percentage …
countries. Pakistan has emerged with the highest prevalence of diabetes by percentage …
DIABETES MELLITUS: CLASIFICACIÓN
EY PATOGENIA - Diabetes. Secretos, 2024 - books.google.com
1.¿ Cuáles son los criterios diagnósticos de diabetes mellitus y prediabetes? En la tabla 1.1
se presentan los criterios diagnósticos de diabetes mellitus. En ausencia de una …
se presentan los criterios diagnósticos de diabetes mellitus. En ausencia de una …
[PDF][PDF] Prevenção primária de Doença Cardiovascular Aterosclerótica (DCVA) e Diabetes Mellitus tipo 2 (DM2) em pacientes em risco metabólico: uma diretriz de …
JL Rosenzweig, GL Bakris, LF Berglund, MF Hivert… - endocrine.org
Objetivo| Desenvolver diretrizes de prática clínica para a prevenção primária de doença
cardiovascular aterosclerótica (DCVA) e diabetes mellitus tipo 2 (DM2) para os indivíduos …
cardiovascular aterosclerótica (DCVA) e diabetes mellitus tipo 2 (DM2) para os indivíduos …
[PDF][PDF] Prevención primaria de la ASCVD y de la T2DM en pacientes con riesgo metabólico: Guía de práctica clínica de Endocrine Society
JL Rosenzweig, GL Bakris, LF Berglund, MF Hivert… - endocrine.org
Objetivo| Desarrollar guías de práctica clínica para la prevención primaria de la enfermedad
cardiovascular aterosclerótica (atherosclerotic cardiovascular disease, ASCVD) y de la …
cardiovascular aterosclerótica (atherosclerotic cardiovascular disease, ASCVD) y de la …